CHAPEL HILL, N.C.--(BUSINESS WIRE)--
POZEN Inc. (POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief Executive Officer, will present at the Piper Jaffray 25th Annual Healthcare Conference on Tuesday, December 3, 2013 at 12:30 p.m. (ET) at the New York Palace Hotel. The presentation will be webcast and available for replay on POZEN’s home page at www.pozen.com.
POZEN Inc. is a small pharmaceutical company that specializes in developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years. Funded by these milestones/royalty streams, POZEN has created a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the opportunities for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit www.pozen.com.
- Health Care Industry
- Investment & Company Information
- pharmaceutical company
- Piper Jaffray
Bill Hodges, Chief Financial Officer, 919-913-1030
Stephanie Bonestell, Manager, Investor Relations & Public Relations, 919-913-1030